Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century.

Latest News

  • Archangels Wins ‘Investor of the Year’ at Scottish Tech Startup Awards

    Investor of the Year Award Winner:  Archangels On 29th November 2018, the team behind Scottish tech conference, Turing Fest, held the first ever Scottish Tech Startup Awards to recognise the people and companies leading the way in building the country’s digital economy. The awards were presented at an end-of-year party, bringing together all those working […]

  • Archangels’ Investee Company ZoneFox acquired by Fortinet

    Leading cyber security software specialist, ZoneFox has been sold by its shareholders Leading cyber security software specialist, ZoneFox, has been sold by its shareholders – including Scottish business angel investment syndicates, Archangels and TriCap, Scottish Investment Bank and Napier University – to US-based Fortinet. ZoneFox was established in 2010 and focuses on providing world-class security […]

  • Speech Graphics Join the Archangels’ Portfolio

      World-leading speech technology business sets sights on global customer service market following £2m investment. The team behind Lara Croft’s smile in the newly launched bestselling Shadow of the Tomb Raider video game are turning their technology sights on the customer service sector following a significant funding boost. Speech Graphics is an Edinburgh and California based […]

  • Archangels and Maven Co-Lead £2.8m Investment in Optoscribe

        Optoscribe is set to increase its manufacturing capacity and engineering resource to meet significant customer demand. Optoscribe, a leading supplier of glass-based integrated photonics components, today announced that the company has closed an investment round of £2.8 million. This funding will facilitate an expansion of current manufacturing capacity, the hiring of key engineering […]

  • New Funding for MGB Biopharma to Support Fight Against C. difficile

        MGB BioPharma Receive New Funding to Support Global Fight Against C. difficile Infection A novel anti-bacterial agent which has been developed in Scotland by MGB Biopharma (MGB) for the treatment of Clostridium difficile infections, is to enter Phase II clinical trials following a newly-completed £1.3m fund raise from existing and new investors, supplementing […]

  • CALCIVIS raises £3.15 million to Fund PMA Approval

    CALCIVIS has raised £3.15 million to Fund PMA Approval of the CALCIVIS® Imaging System ahead of a Planned US Launch in 2019.  Proceeds will also be used to drive sales and optimise the commercial model for this novel imaging system in the UK. CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay […]

Company portfolio

  • Archangel Investors Ltd
  • Archangel Investors Ltd
  • Archangel Investors Ltd
  • RT @BDD_Pharma: Well the weather outside is frightful. But our formulations are so delightful! We would like to wish our clients and friend…
    Archangel Investors Ltd about 6 days ago
  • RT @reactec: Reactec are proud to be shortlisted for Innovation of the Year (Non-Contractor) Category. HAVwear system and it's ability to d…
    Archangel Investors Ltd about 12 days ago
  • RT @GetAdministrate: If you're interested in working for us, head to our careers page to see what we have on offer! https://t.co/46NOBHa48X…
    Archangel Investors Ltd about 18 days ago

See our ‘Impact evaluation of activities report’ by the Hunter Centre for Entrepreneurship at The University of Strathclyde.